Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - TOTAL CURRENT ASSETS
Total Current Assets CRVS - Corvus Pharmaceuticals, Inc.
28 M
LAST VALUE
-36.55%
2 YEAR CAGR
-24.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR